AGM Statement

The MedicX Fund Limited 11 February 2008 For Immediate Release 11 February 2008 MedicX Fund Limited ('MedicX Fund', 'the Fund' or 'the Company') AGM Statement MedicX Fund Limited (LSE: MXF), the specialist investor in modern purpose built primary healthcare properties in the United Kingdom, announces that at the annual general meeting to be held later today the Chairman will make the following statement. This statement also forms the Company's Interim Management Statement relating to the period from 1 October 2007 to today's date. 'I am pleased to report that the MedicX Fund has performed in line with expectations for the period since 1 October 2007. The Company has completed the development of three properties at Evesham, Wollaton and Rothwell during this period. The Company has also entered into forward funding agreements to acquire three more primary care medical centres at Lytham, Gosberton and Castlecroft. The total acquisition cost of the properties is £18.2 million. To date the Company has investments and commitments amounting to £161 million across 45 properties. It continues to have a strong pipeline of investment opportunities and is on track to invest £200 million by mid-2008. The portfolio of properties is performing in line with our long-term objectives and there are no material operational or financial issues to report. The recent reduction in values in the commercial property sector has impacted the primary care property sector. However, due to the quality of the income from the asset class we believe that the impact has been relatively limited and does not, in our opinion, impact the long term attractiveness of the sector. One of the benefits of the adjustment in values is that it has enabled the group to make acquisitions at attractive levels. We are optimistic about the prospects for the MedicX Fund. On 11 January 2008 a dividend of 2.5p per ordinary share was paid to shareholders, making a total of 5p per share for the year. We intend to maintain our progressive dividend policy.' Jorge Tavares Chairman Information on MedicX Fund Limited MedicX Fund Limited ('MXF' or the 'Company', or together with its subsidiaries, the 'Group') the specialist investor in modern purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange in November 2006. It has committed investment of £161 million and a portfolio of 45 properties. The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority, and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of primary healthcare properties with a team of 31 operating across 4 regional offices. -Ends- For further information please contact: MedicX Fund +44 (0) 1481 723 450 Jorge Tavares, Chairman MedicX Group +44 (0) 0808 2025461 Keith Maddin, Chairman Mike Adams, Managing Director Buchanan Communications +44 (0) 20 7466 5000 Charles Ryland, Partner Mary-Jane Johnson, Partner This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings